Publications by authors named "R Lasica"
Article Synopsis
- * The exact cause of peripartum cardiomyopathy is unclear, although factors like age, lifestyle, and genetics may play a role; recent theories suggest that an abnormal form of prolactin may contribute to the heart damage.
- * Ongoing research explores treatments like bromocriptine, a drug that inhibits prolactin, and highlights the importance of safe medication use during pregnancy and breastfeeding, particularly to protect both mothers and their babies.
Background: In the post-COVID-19 era, there is growing concern regarding its impact on cardiovascular health and the following effects on the overall quality of life of affected individuals. This research seeks to investigate cardiac magnetic resonance (CMR) findings following COVID-19 and their impact on the quality of life of affected individuals.
Methods: An observational, cross-sectional study was conducted in consecutive patients with persistent cardiovascular symptoms after COVID-19 who were referred to CMR due to suspected myocardial injury.
Background: stress hyperglicemia (SH) is common in patients with ST-elevation myocardial infraction (STEMI). The aims of this study were to analyze the impact of SH on the incidence of all-cause mortality and major adverse cardiovascular events (MACE-cardiovascular death, nonfatal reinfarction, target vessel revascularization, and stroke) in STEMI patients without diabetes mellitus (DM) who have been treated successfully with primary PCI (pPCI).
Method: we analyzed 2362 STEMI patients treated with successful pPCI (post-procedural flow TIMI = 3) and without DM and cardiogenic shock at admission.
Background: A significant percentage of younger patients with myocardial infarction have premature coronary artery disease (CAD). The aims of this study were to analyze all-cause mortality and major adverse cardiovascular events (MACEs cardiovascular death, non-fatal reinfarction, stroke, target vessel revascularization) during eight-year follow-up in patients with ST-elevation myocardial infarction (STEMI) and premature CAD.
Method: We analyzed 2560 STEMI patients without previous CAD and without cardiogenic shock at admission who were treated with primary PCI.
Article Synopsis
- Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), involves long-term liver inflammation that causes damage and can lead to serious conditions like cirrhosis.
- Patients with MASLD are at higher risk for cardiovascular diseases due to shared issues in lipid metabolism and the harmful effects of lipotoxicity.
- Currently, there is no specific medication for MASLD, but lifestyle changes are recommended, and recent trials are exploring existing drugs that might also benefit MASLD patients.